ANTIGENICS, INC.

Company

AGENUS INC

Filed

May 1, 2001

Accession Number

0000950135-01-500922

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →